AIML Financial Statements From 2010 to 2025
| AIMLF Stock | USD 0.08 0.01 6.94% |
Check AIML Innovations financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AIML Innovations' main balance sheet or income statement drivers, such as , as well as many indicators such as . AIML financial statements analysis is a perfect complement when working with AIML Innovations Valuation or Volatility modules.
AIML |
AIML Innovations OTC Stock Shares Outstanding Analysis
AIML Innovations' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current AIML Innovations Shares Outstanding | 36.69 M |
Most of AIML Innovations' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AIML Innovations is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, AIML Innovations has 36.69 M of shares currently outstending. This is 79.68% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The shares outstanding for all United States stocks is 93.58% higher than that of the company.
AIML Innovations Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AIML Innovations's current stock value. Our valuation model uses many indicators to compare AIML Innovations value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AIML Innovations competition to find correlations between indicators driving AIML Innovations's intrinsic value. More Info.AIML Innovations is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AIML Innovations' earnings, one of the primary drivers of an investment's value.About AIML Innovations Financial Statements
AIML Innovations stakeholders use historical fundamental indicators, such as AIML Innovations' revenue or net income, to determine how well the company is positioned to perform in the future. Although AIML Innovations investors may analyze each financial statement separately, they are all interrelated. For example, changes in AIML Innovations' assets and liabilities are reflected in the revenues and expenses on AIML Innovations' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AIML Innovations. Please read more on our technical analysis and fundamental analysis pages.
AIML Innovations Inc. operates in the digital healthcare business using artificial intelligence and machine learning . AIML Innovations Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. AiMl Innovations is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in AIML OTC Stock
AIML Innovations financial ratios help investors to determine whether AIML OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AIML with respect to the benefits of owning AIML Innovations security.